<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210108049969N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-01-10</date_registration>
      <primary_sponsor>Khoram-Abad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of ketamine and oxytocin on pain control, nausea, blood pressure, heart rate, satisfaction, postoperative blood oxygen saturation in patients undergoing elective laparoscopic gallbladder surgery</public_title>
      <acronym></acronym>
      <scientific_title>The effect of ketamine and oxytocin on postoperative pain control in patients undergoing elective laparoscopic gallbladder surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-12-14</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/53576</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Random number table
Random number table
Table of Random Numbers A set of masses of
Numbers that are produced without a specific pattern or order and in a completely random manner and are in the form of a table. In order to use a random number table, the researcher must first preset the table to read the numbers (for example, up, down, left, or right (the researcher's second assumption is to consider numbers for different groups), for example, even numbers for intervention. A and odd numbers for
Intervention B, another method of taking the number 0-40 for intervention A and the number 41-80 for
 Intervention B is the numbers 120-181 for group C, then the researcher touches one of the numbers and moves in one of the predetermined directions and records the numbers and
Allocates different groups, Blinding description: All blind people only know that participants are divided into 4 groups, but do not know the type of treatment intervention in each group to control pain, nausea, hemodynamic changes such as blood pressure and heart rate, arterial oxygenation and patient satisfaction, and assign patients in 4 groups. It was done completely randomly through a table of random numbers, which is described as how to do it.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Status and comparison of pain after laparoscopic cholecystectomy in 3 study group. Condition 2: Status and comparison of nausea after laparoscopic cholecystectomy in 3 study group. Condition 3: Status and comparison of hemodynamic changes (blood pressure, heart rate, blood oxygenation) after laparoscopic cholecystectomy in 3 study group.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Receiving 0.5 mg of ketamine per kg of patient weight and oxytocin 0.5 units per kg of patient weight immediately after patient extubation. All of the following were similar in all three groups: Time Operation ١ - ٢ Hour, drugs used during surgery (for premedication of fentanyl 1-2 micrograms per kilogram - Midaz slide 0/05-0/15mg per kg body weight - Atracorium 0/5mg per kg Kg patient weight, propofol 1.5-2/5 mg / kg body weight, under isoflurane1/2% inhalation anesthesia as maintenance anesthetic, similar serum therapy. Intervention 2: Intervention group: Receiving 0.5 mg of pethidine per kg of patient weight is prescribed immediately after the patient's extubation. All of the following were the same in all three groups: time of operation 1-2 hour, intraoperative drugs (for premedication from Fentanyl  1-2 micrograms per kilogram - Midazolam 0/05-0/15 milligrams per kilogram body weight - Atracorium 0.5 mg per kilogram patient weight, Propofol 1.5-2.5 mg Per kilogram of body weight, under inhaled anesthesia with iso-fluorine 1/2 ٪ as maintenance anesthetic, similar serum therapy. Intervention 3: Control group: Do not receive medication, however, each group was prescribed 4 mg of ondansetron and 5 micrograms of sufentanil after extubation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Privacy of the patients</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Maryam Baghizadeh Baghdashti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enqelab Ave,Shohadaye-Ashayer Hospital</address>
        <city>Khoram-Abad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6816933132</zip>
        <telephone>+98 66 3323 6401</telephone>
        <email>M.baghizadeh65@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Arash Karimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Enqelab Ave,Shohadaye -Ashayer Hospital</address>
        <city>Khoram-Abad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6816933132</zip>
        <telephone>+98 66 3323 6401</telephone>
        <email>M.baghizadeh65@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients aged 30-60 years who have undergone laparoscopic cholecystectomy
No pulmonary disease
ASA class 1(American Society of Anesthesiologists ) is a system for assessing the fitness of patients before surgery
No history of chronic pain after surgery</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of chronic pain
Specific drug dependence such as opium
History of psychiatric illness</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Receiving 0.5 mg of ketamine per kg of patient weight and oxytocin 0.5 units per kg of patient weight immediately after patient extubation. All of the following were similar in all three groups: Time Operation ١ - ٢ Hour, drugs used during surgery (for premedication of fentanyl 1-2 micrograms per kilogram - Midaz slide 0/05-0/15mg per kg body weight - Atracorium 0/5mg per kg Kg patient weight, propofol 1.5-2/5 mg / kg body weight, under isoflurane1/2% inhalation anesthesia as maintenance anesthetic, similar serum therapy</i_keyword>
      <i_keyword>Intervention group: Receiving 0.5 mg of pethidine per kg of patient weight is prescribed immediately after the patient's extubation. All of the following were the same in all three groups: time of operation 1-2 hour, intraoperative drugs (for premedication from Fentanyl  1-2 micrograms per kilogram - Midazolam 0/05-0/15 milligrams per kilogram body weight - Atracorium 0.5 mg per kilogram patient weight, Propofol 1.5-2.5 mg Per kilogram of body weight, under inhaled anesthesia with iso-fluorine 1/2 ٪ as maintenance anesthetic, similar serum therapy</i_keyword>
      <i_keyword>Control group: Do not receive medication, however, each group was prescribed 4 mg of ondansetron and 5 micrograms of sufentanil after extubation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score based on visual analague scale. Timepoint: After surgery in the recovery room, 1 and 2 hours after surgery. Method of measurement: Visual analogue scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Arash karimi-maryam baghizadeh</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-12-01</approval_date>
        <contact_name>Ethics Committee of Lorestan University of Medical Sciences</contact_name>
        <contact_address>Moallem St., Shahid Anoushirvan Rezaei Sq., University of Medical Sciences Khoram-Abad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
